Skip to main content

Eva Polverino

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Eva Polverino

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y metástasis por células estrelladas carentes de CFTR.

IP: Molero Richard, Francesc Xavier
Collaborators: Campderros Traver, Laura, Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y, Polverino , Eva
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI22/00887
Duration: 01/01/2023 - 31/12/2025

Grup de Recerca en Pneumologia

IP: Ferrer Sancho, Jaume
Collaborators: Martí Beltran, Sergi, Arjona Perís, Marta Vicenta, Romero Mesones, Christian Eduardo, Jiménez Fuentes, Maria Angeles, Jurado Luque, Mª Jose, Miravitlles Fernández, Marc, Villar Gomez, Ana, Álvarez Fernandez, Antonio, Monforte Torres, Victor, Romero Santo-Tomas, Odile, Barrecheguren Fernández, Miriam, Clofent Alarcón, David, Bravo Masgoret, Carles, Culebras Amigo, Mario, Muñoz Gall, Fco. Javier, Sampol Rubio, Gabriel, Ramon Belmonte, Maria Antonia, Pallero Castillo, Mercedes, Cruz Carmona, Mª Jesús, Berastegui Garcia, Cristina, Felipe Montiel, Almudena, Orriols Torras, Gerard, Grup de Recerca en Pneumologia, Boada Perez, Meritxell, Grup de Recerca en Pneumologia, López Meseguer, Manuel, Soler Segovia, David, Gómez Olles, Susana, Grup de Recerca en Pneumologia, Saez Gimenez, Berta, Grup de Recerca en Pneumologia, Ojanguren Arranz, Iñigo, Polverino , Eva, Grup de Recerca en Pneumologia, Traversi , Letizia
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 31/12/2024

ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) H2020-SC1-2020-Single-Stage-RTD Grant agreement ID: 965313

IP: Polverino , Eva
Collaborators: Kruger , Monica
Funding agency: EUROPEAN COMMISSION
Funding: 21875
Reference: ECRAID-H2020-SC1-BHC-35-2020
Duration: 01/03/2021 - 28/02/2026

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: Pujol Borrell, Ricardo
Collaborators: Hernández González, Manuel, Martínez Gallo, Mónica, Labrador Horrillo, Moisés, Codina Grau, Gema, Albert Blanco Grau, Antón Pagarolas, Andres, Álvarez Fernandez, Antonio, Fernández Hidalgo, Nuria, Roser Ferrer Costa, Esteve Ribera Pascuet, Ruiz Rodriguez, Juan Carlos, Ferrer Sancho, Jaume, Suy Franch, Anna, Soler Palacín, Pere, Selva O'Callaghan, Albert, Pumarola Suñé, Tomàs, Ruiz Camps, Isabel, Miarons Font , Marta, Alvarez De la Sierra, Daniel, Martín Nalda, Andrea, Polverino , Eva, Romina Dieli Crimi, Dieli Crimi, Romina
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Jose Cabral Jamba

Jose Cabral Jamba

Administrative
IT / Information Systems
Digital Transformation and Quality Area
Read more
Sebastián  Sandoval  Moreno

Sebastián Sandoval Moreno

Predoctoral researcher
Rheumatology
Read more
Daniel López Torres

Daniel López Torres

Read more
Mónica López Bardasco

Mónica López Bardasco

Administrative
Employment Relations Unit
Human Resources and Lega Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.